Pre-treatment with allopurinol is able markedly to attenuate the deterioration in blood viscosity (BV) and whole blood filterability (WBF) that occurs after ischaemia during exercise. It also reduces the exercise-induced increase in serum oxidase activity, although this action is slightly less effective in peripheral obliterative arterial disease (POAD) patients. Conversely, allopurinol is completely ineffective in modifying haemorheological parameters in vitro, and it does not affect superoxide anion generation or enzyme release from neutrophils stimulated in vitro with formyl-methionyl-leucyl-phenylalanine (FMLP). It is suggested that allopurinol may attenuate changes in BV and WBF by affecting xanthine-oxidase-dependent free radical formation in tissues.

Capecchi, P.L., Pasini, F.L., Pasqui, A.L., Orrico, A., Ceccatelli, L., Acciavatti, A., et al. (1988). Allopurinol prevents ischaemia-dependent haemorheological changes. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 35(5), 475-481 [10.1007/BF00558241].

Allopurinol prevents ischaemia-dependent haemorheological changes

Capecchi, P. L.;Pasqui, A. L.;Orrico, A.;Ceccatelli, L.;Acciavatti, A.;Pieragalli, D.;Di Perri, T.
1988-01-01

Abstract

Pre-treatment with allopurinol is able markedly to attenuate the deterioration in blood viscosity (BV) and whole blood filterability (WBF) that occurs after ischaemia during exercise. It also reduces the exercise-induced increase in serum oxidase activity, although this action is slightly less effective in peripheral obliterative arterial disease (POAD) patients. Conversely, allopurinol is completely ineffective in modifying haemorheological parameters in vitro, and it does not affect superoxide anion generation or enzyme release from neutrophils stimulated in vitro with formyl-methionyl-leucyl-phenylalanine (FMLP). It is suggested that allopurinol may attenuate changes in BV and WBF by affecting xanthine-oxidase-dependent free radical formation in tissues.
Capecchi, P.L., Pasini, F.L., Pasqui, A.L., Orrico, A., Ceccatelli, L., Acciavatti, A., et al. (1988). Allopurinol prevents ischaemia-dependent haemorheological changes. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 35(5), 475-481 [10.1007/BF00558241].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1002140
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo